Importantly, this study delineates the involvement of SP3-461aa in activating the MYH9/PI3K-Akt signaling pathway, offering insights into the molecular dynamics of ccRCC progression. The gene discussed is SP3; the disease is nonpapillary renal cell carcinoma.